VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 59 filers reported holding VOR BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,343,758 | -31.4% | 633,848 | 0.0% | 0.01% | -27.3% |
| Q2 2023 | $1,958,590 | -42.6% | 633,848 | 0.0% | 0.01% | -42.1% |
| Q1 2023 | $3,410,102 | -65.0% | 633,848 | -56.8% | 0.02% | -67.8% |
| Q4 2022 | $9,748,401 | +67.1% | 1,465,925 | 0.0% | 0.06% | +55.3% |
| Q3 2022 | $5,834,000 | +3.1% | 1,465,925 | +28.7% | 0.04% | +18.8% |
| Q2 2022 | $5,660,000 | – | 1,138,768 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,692,429 | $288,444,000 | 51.94% |
| Trustees of Columbia University in the City of New York | 183,821 | $7,923,000 | 9.60% |
| RA Capital Management | 11,120,973 | $479,314,000 | 7.23% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $46,318,000 | 6.00% |
| Sarissa Capital Management LP | 707,010 | $30,472,000 | 2.92% |
| SECTORAL ASSET MANAGEMENT INC | 535,259 | $23,070,000 | 1.75% |
| Woodline Partners LP | 1,153,267 | $49,706,000 | 1.10% |
| Artal Group S.A. | 550,000 | $23,705,000 | 0.42% |
| Orbimed Advisors | 833,333 | $35,917,000 | 0.34% |
| Laurion Capital Management LP | 585,667 | $25,242,000 | 0.14% |